As a consequence, the German S3-guidelines for the diagnosis and treatment of EDs recommend excluding a diagnosis of inflammatory bowel disease (M. Crohn) by measuring calprotectin in stool, which is present in large quantities in the case of inflammation, and excluding a diagnosis of celiac disease by determining Tissue Transglutaminase IgA antibody and IgA antibodies, the latter of which is done to ensure that the patient produces enough IgA antibodies to render the analysis accurate (AWMF 2018, www.awmf.org/leitlinien/detail/ll/051-026.html). Here, CD79A is linked to celiac disease.